The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Transcatheter Valve Replacement in Severe Tricuspid Regurgitation
Abstract
BACKGROUND: Severe tricuspid regurgitation is associated with disabling symptoms and an increased risk of death. Data regarding outcomes after percutaneous transcatheter tricuspid-valve replacement are needed. METHODS: In this international, multicenter trial, we randomly assigned 400 patients with severe symptomatic tricuspid regurgitation in a 2:1 ratio to undergo either transcatheter tricuspid-valve replacement and medical therapy (valve-replacement group) or medical therapy alone (control group). The hierarchical composite primary outcome was death from any cause, implantation of a right ventricular assist device or heart transplantation, postindex tricuspid-valve intervention, hospitalization for heart failure, an improvement of at least 10 points in the score on the Kansas City Cardiomyopathy Questionnaire overall summary (KCCQ-OS), an improvement of at least one New York Heart Association (NYHA) functional class, and an improvement of at least 30 m on the 6-minute walk distance. A win ratio was calculated for the primary outcome by comparing all possible patient pairs, starting with the first event in the hierarchy. RESULTS: A total of 267 patients were assigned to the valve-replacement group and 133 to the control group. At 1 year, the win ratio favoring valve replacement was 2.02 (95% confidence interval [CI], 1.56 to 2.62; P<0.001). In comparisons of patient pairs, those in the valve-replacement group had more wins than the control group with respect to death from any cause (14.8% vs. 12.5%), postindex tricuspid-valve intervention (3.2% vs. 0.6%), and improvement in the KCCQ-OS score (23.1% vs. 6.0%), NYHA class (10.2% vs. 0.8%), and 6-minute walk distance (1.1% vs. 0.9%). The valve-replacement group had fewer wins than the control group with respect to the annualized rate of hospitalization for heart failure (9.7% vs. 10.0%). Severe bleeding occurred in 15.4% of the valve-replacement group and in 5.3% of the control group (P = 0.003); new permanent pacemakers were implanted in 17.4% and 2.3%, respectively (P<0.001). CONCLUSIONS: For patients with severe tricuspid regurgitation, transcatheter tricuspid-valve replacement was superior to medical therapy alone for the primary composite outcome, driven primarily by improvements in symptoms and quality of life. (Funded by Edwards Lifesciences; TRISCEND II ClinicalTrials.gov number, NCT04482062.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab395 · Cited by 5,685
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
Self-citationOtto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000932 · Cited by 2,449
Self-citationTranscatheter Repair for Patients with Tricuspid Regurgitation
Sorajja, P., Whisenant, B., Hamid, N., Naik, H., Makkar, R., Tadros, P., Price, M. J., Singh, G., Fam, N., Kar, S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2300525 · Cited by 930
Self-citationPocock, S. J., Ariti, C. A., Collier, T. J., & Wang, D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr352 · Cited by 812
Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis
Fergusson, D., Aaron, S. D., Guyatt, G., & Hébert, P. (2002) · BMJ · doi:10.1136/bmj.325.7365.652 · Cited by 708
Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care
Spertus, J. A., Jones, P. G., Sandhu, A. T., & Arnold, S. V. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.09.542 · Cited by 619
The need for a new tricuspid regurgitation grading scheme
Hahn, R. T., & Zamorano, J. L. (2017) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jex139 · Cited by 574
Self-citationCombining mortality and longitudinal measures in clinical trials
Finkelstein, D. M., & Schoenfeld, D. A. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990615)18:11<1341::aid-sim129>3.0.co;2-7 · Cited by 363
Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation
Gammie, J. S., Chu, M. W. A., Falk, V., Overbey, J. R., Moskowitz, A. J., Gillinov, M., Mack, M. J., Voisine, P., Krane, M., Yerokun, B., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2115961 · Cited by 267
Self-citationHahn, R. T. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2216709 · Cited by 249
Self-citationContemporary Trends in the Use and Outcomes of Surgical Treatment of Tricuspid Regurgitation
Alqahtani, F., Berzingi, C. O., Aljohani, S., Hijazi, M., Al‐Hallak, A., & Alkhouli, M. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007597 · Cited by 246
Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study
Kodali, S., Hahn, R. T., Makkar, R., Makar, M., Davidson, C. J., Puthumana, J. J., Zahr, F., Chadderdon, S., Fam, N., Ong, G., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad667 · Cited by 232
Self-citationShoemaker, M. J., Curtis, A. B., Vangsnes, E., & Dickinson, M. G. (2013) · Cardiopulmonary Physical Therapy Journal · doi:10.1097/01823246-201324030-00004 · Cited by 226
Hahn, R. T., Lawlor, M. K., Davidson, C. J., Badhwar, V., Sannino, A., Spitzer, E., Lurz, P., Lindman, B. R., Topilsky, Y., Baron, S. J., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.008 · Cited by 212
Self-citationContemporary Etiologies, Outcomes, and Novel Risk Score for Isolated Tricuspid Regurgitation
Wang, T. K. M., Akyuz, K., Mentias, A. G., Kirincich, J., Durán-Crane, A., Xu, S., Popović, Z., Xu, B., Gillinov, A. M., Pettersson, G., et al. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2021.10.015 · Cited by 116
Chen, Q., Bowdish, M. E., Malas, J., Roach, A., Gill, G., Rowe, G., Thomas, J., Emerson, D. A., Trento, A., Egorova, N., et al. (2023) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2022.12.041 · Cited by 81
Arnold, S. V., Goates, S., Sorajja, P., Adams, D. H., von Bardeleben, R. S., Kapadia, S. R., & Cohen, D. J. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.10.008 · Cited by 77
Self-citationGerçek, M., Narang, A., Körber, M. I., Friedrichs, K. P., Puthumana, J. J., Ivannikova, M., Al‐Kazaz, M., Cremer, P. C., Baldridge, A. S., Meng, Z., et al. (2024) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2024.04.008 · Cited by 72
Self-citationTricuspid Regurgitation in Patients With Heart Failure and Preserved Ejection Fraction
Hahn, R. T., Lindenfeld, J. M., Böhm, M., Edelmann, F., Lund, L. H., Lurz, P. C., Metra, M., Tedford, R. J., Butler, J., & Borlaug, B. A. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.04.047 · Cited by 64
Self-citationSannino, A., Ilardi, F., Hahn, R. T., Lancellotti, P., Lurz, P. C., Smith, R. L., Esposito, G., & Grayburn, P. A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.919395 · Cited by 50
Self-citationEVOQUE Tricuspid Valve Replacement System
Hahn, R. T., Makkar, R., Makar, M. M., Davidson, C. J., Puthamana, J., Zahr, F. E., Chadderdon, S. M., Fam, N., Ong, G., Yadav, P., et al. (2024) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2024.07.034 · Cited by 50
Self-citationCai, S., Bowers, N., Dhoot, A. S., Ho, E. C., Ong, G., Eckstein, J., Edwards, J. M., Fam, N., & Connelly, K. A. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.07.018 · Cited by 44
TRISCEND II: Novel Randomized Trial Design for Transcatheter Tricuspid Valve Replacement
Grayburn, P. A., Kodali, S., Hahn, R. T., Lurz, P. C., Thourani, V. H., Kozorovitsky, E. R., Gilmore, S. Y., Vinekar, C., Zhang, B., Boulware, K., et al. (2024) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2024.06.009 · Cited by 34
Self-citationKassab, J. T., Harb, S. C., Desai, M. Y., Gillinov, A. M., Layoun, H., Dahdah, J. E., Helou, M. C. E., Nakhla, S., Elgharably, H., Kapadia, S. R., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032760 · Cited by 32
Self-citationDeterminants of Tricuspid Regurgitation Progression and Its Implications for Adequate Management
Bolumburu, A. A., Ruiz, J. M. M., Mahía, P., David, E. P., González‐Alujas, T., Sitges, M., Li, C., Alonso, D., Carrasco, F., Morales, M. L., et al. (2023) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2023.10.006 · Cited by 31
Pacemaker implantation following tricuspid valve annuloplasty
Ragnarsson, S., Taha, A., Nielsen, S. J., Amabile, A., Geirsson, A., Krane, M., Mörtsell, D., Sjögren, J. L., Jeppsson, A., & Martinsson, A. (2023) · JTCVS Open · doi:10.1016/j.xjon.2023.08.017 · Cited by 17
Arnold, S. V., Spertus, J. A., GOSCH, K. L., Dunlay, S. M., Olds, D. M., Jones, P. G., Bocell, F. D., Wu, C., & Cohen, D. J. (2024) · medRxiv · doi:10.1101/2024.02.07.24302462 · Cited by 4
Understanding Treatment Preferences for Patients with Tricuspid Regurgitation
Iyer, V., Faza, N. N., Pfeiffer, M. P., Kozak, M., Peterson, B. R., von Ballmoos, M. W., Mollenkopf, S. A., Mancilla, M., Latibeaudiere, D., & Reardon, M. J. (2024) · MDM Policy & Practice · doi:10.1177/23814683231225667 · Cited by 2
Cited by
2025 ESC/EACTS Guidelines for the management of valvular heart disease
Praz, F., Borger, M. A., Lanz, J., Marin-Cuartas, M., Abreu, A., Adamo, M., Ajmone Marsan, N., Barili, F., Bonaros, N., Cosyns, B., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf194 · Cited by 1,072
Self-citationKumbhani, D. J., Armbruster, A. L., Cheng, R. K., Chrispin, J., Fischer, U., Holbrook, A. M., Joglar, J., & Sevestre, M.-A. (2026) · JACC · doi:10.1016/j.jacc.2026.05.033 · Cited by 2
Metadata
- Authors
- Hahn, R. T., Makkar, R., Thourani, V. H., Makar, M., Sharma, R. P., Haeffele, C., Davidson, C. J., Narang, A., O’Neill, B., Lee, J., Yadav, P., Zahr, F., Chadderdon, S., Eleid, M., Pislaru, S., Smith, R., Szerlip, M., Whisenant, B., Sekaran, N. K., Garcia, S., Stewart-Dehner, T., Thiele, H., Kipperman, R., Koulogiannis, K., Lim, D. S., Fowler, D., Kapadia, S., Harb, S. C., Grayburn, P. A., Sannino, A., Mack, M. J., Leon, M. B., Lurz, P., & Kodali, S. K.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2025-01-09
- Volume
- 392
- Issue
- 2
- Pages
- 115-126
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4403886925
- Cited by
- 376
- References
- 29
- FWCI
- 101.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.